2016 American Transplant Congress » Poster Session A: Kidney: Acute Cellular Rejection

Date: Saturday, June 11, 2016

Time: 5:30pm-7:30pm

Location: Halls C&D

Session Type: Poster Session

Meeting: 2016 American Transplant Congress

5:30pm-7:30pm: A Novel Quantitative CD45 Immunofluorescence Assay Can Measure Inflammatory Load in Renal Transplant Biopsies with Excellent Reproducibility and Repeatability.

Z. Laszik,¹ D. Dobi,¹ L. Laszik,¹ D. Ikle,² S. Chandran,¹ F. Vincenti.¹

5:30pm-7:30pm: A Quantitative CD45 Assay May Improve Diagnostic Accuracy of the Diagnosis of Acute Cellular Rejection in Transplant Kidney Biopsies.

L. Laszik, S. Bowman, V. Walavalkar, F. Vincenti, Z. Laszik.

5:30pm-7:30pm: A Quantitative CD45 Immunohistochemical Assay Allows Precise and Reproducible Measurement of Inflammation in Renal Transplant Biopsies.

V. Walavalkar,¹ S. Bowman,¹ L. Laszik,¹ D. Ikle,² S. Chandran,¹ F. Vincenti,¹ Z. Laszik.¹

5:30pm-7:30pm: Acute Allograft Glomerulopathy: A Distinct Form of Cellular Rejection.

O. AL-Badri, M. Alexander, F. Cosio, L. Cornell.

5:30pm-7:30pm: Acute Rejection Profoundly Impacts Graft Survival in Young but Not in Old Kidney Transplant Recipients.

C. Denecke,^1,3 M. Biebl,^1,3 J. Fritz,² A. Brandl,^1,4 S. Weiss,^1,4 T. Dziodzio,^1,3 F. Aigner,^1,3 R. Sucher,^1,3 C. Bösmüller,¹ J. Pratschke,^1,3,4 R. Öllinger.^1,3

5:30pm-7:30pm: Analysis of T Cell Receptor Repertoire in Routine Renal Allograft Biopsy.

R. Reindl-Schwaighofer,¹ J. Weinberger,¹ R. Jimenez-Heredia,¹ J. Sunzenauer,¹ S. Schaller,² S. Winkler,² R. Oberbauer.¹

5:30pm-7:30pm: Biopsies for Delayed Graft Function After Alemtuzumab Induction in Kidney Transplantation: The Incidence of Early Rejection After Alemtuzumab Is Very Low but Not Negligible.

E. McGuire, C. Roufosse, T. Cook, D. Ashby, T. Cairns, J. Galliford, M. Willicombe, D. Taube, A. McLean.

5:30pm-7:30pm: Clinical Impact of Pre-Transplant Serum 25-Hydroxyvitamin D Levels on the Post-Transplant Immunologic and Non-Immunologic Outcomes in Kidney Transplant Recipients.

T. Ban,^1,2 J. Kim,^1,2 Y. Lee,¹ B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y.-S. Kim,^1,2 B. Chung.^1,2

5:30pm-7:30pm: Clinical Outcome in Pure T-Cell Mediated Acute Rejection of the Kidney with No Donor Specific Antibody or C4d Staining.

P. Randhawa,¹ G. Huang,² S. Randhawa,¹ G. Zeng,¹ X. Zhao.³

5:30pm-7:30pm: Comparison of Efficacy and Safety of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus.

P. Gatault,¹ N. Kamar,² M. Buchler,¹ C. Colosio,³ D. Bertrand,⁴ A. Durrbach,⁵ L. Albano,⁶ J. Rivalan,⁷ M. Essig,⁸ Y. Le Meur,⁹ N. Bouvier,¹⁰ B. Charpentier,⁵ E. Thervet,¹¹ L. Rostaing,² Y. Lebranchu.¹

5:30pm-7:30pm: Comparison of Pharmacokinetic and Clinical Outcomes of Tacrolimus Hexal^® with Prograf^® Based Regimen in De Novo Kidney Transplant Recipients: Results from the Randomized, SparTacus Study.

W. Arns,¹ A. Huppertz,¹ T. Rath,¹ S. Ziefle,¹ L. Rump,¹ A. Hansen,¹ D. Baeumer,² K. Budde,¹ L. Lehner,¹ T. Klein,¹ P. Schenker.¹

5:30pm-7:30pm: Continuous Antithymocyte Globulin (rATG) for Treatment of Renal Allograft Rejection: Preliminary Analysis of a Prospective, Randomized Trial.

S. Patel, R. Knight, S. Kuten, J. Nolte, A. Gaber.

5:30pm-7:30pm: Cytokine Networks in Kidney Transplant Patients.

R. Sabat,¹ E. Witte,¹ P. Reinke,² K. Wolk,¹ N. Babel.^3,4

5:30pm-7:30pm: End Stage Renal Disease Patients Have a Skewed T Cell Receptor Vbeta Repertoire.

L. Huang,¹ A. Langerak,² I. Wolvers - Tettero,² R. Meijers,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹

5:30pm-7:30pm: Exposure Analysis for the Composite Efficacy Endpoints in the US92 Phase 3 Kidney Transplantation Trial to Understand Center Effects.

F. Shihab, B. Kaplan, K. McCague, D. Patel, F. Vincenti.

5:30pm-7:30pm: Higher Pre-Transplant Triglyceride Levels Are Associated with Increased Acute Cellular Rejection Risk Following Kidney Transplant.

J. Hagopian,¹ D. Brennan,² K. Lentine,³ T. Horwedel.¹

5:30pm-7:30pm: Immunological Ageing-Related Expansion of Highly Differentiated CD4⁺CD28null T Cells Is Associated with a Lower Risk for Early Acute Rejection After Renal Transplantation.

B. Dedeoglu, R. Meijers, M. Klepper, D. Hesselink, C. Baan, N. Litjens, M. Betjes.

5:30pm-7:30pm: NanoString Detection of Gene Signatures in Urine During Acute Cellular Rejection of Kidney Grafts.

K. Keslar,¹ A. Zmijewska,² J. Andriga,² K. Newell,³ R. Mannon,² P. Heeger,⁴ R. Fairchild.¹

5:30pm-7:30pm: Natural Language Processing Methods Allow Reliable Extraction of Banff Scores and Grades.

K. Reilly,¹ L. Lenert,¹ H. Anwar,² J. Thompson,¹ D. Taber,¹ P. Mauldin,¹ T. Srinivas.¹

5:30pm-7:30pm: Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.

D. Zecher,¹ A. Cumpelik,² B. Ruhland,¹ B. Banas,¹ H. Hopfer,³ M. Dickenmann,⁴ J. Schifferli.²

5:30pm-7:30pm: Post-Transplant Reduction of Long Lived Plasma Cells from Peripheral Circulation Is Associated with Acute Rejection in Kidney Transplant Recipients.

R. Minz,¹ R. Dhital,² M. Minz,² R. Nada,³ A. Sharma,² S. Singh,² D. Kenwar.²

5:30pm-7:30pm: Pre-Formed AT1R Antibodies Are Associated with Rejection After Kidney Transplantation.

D. Kim, P. Warner, K. Nelson, I. Gimferrer, C. Johnson, C. Blosser, R. Bakthavatsalam, N. Leca.

5:30pm-7:30pm: Rapid Emergence of CD28^null Cells Following Ex Vivo Restimulation Is Associated with Belatacept Resistant Rejection.

M. Cortes, S. Laurie, B. Sayed, M. Ford.

5:30pm-7:30pm: Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.

D. Keith, G. Vranic, A. Nishio Lucar.

5:30pm-7:30pm: Surveillance Biopsy Findings with Alemtuzumab (ALZ) Induction in Kidney Transplantation.

H. Madariaga,¹ R. Ugarte,¹ C. Drachenberg,² N. Costa,¹ B. Thomas,¹ J. Bromberg,³ M. Weir,¹ A. Haririan.¹

5:30pm-7:30pm: The Impact of Allograft Rejection on DNA Methylation After Kidney Transplantation.

K. Boer, E. de Wit, D. Hesselink, L. Hofland, M. Betjes, C. Baan.

5:30pm-7:30pm: The Impact of Treating Borderline Cellular Rejections.

R. Mustafa,¹ Y. Al Azzi,¹ J. Crew,¹ G. Dube,¹ H. Morris,¹ M. Chiles,¹ J. Chang,¹ H. Fernandez,¹ D. Cohen,¹ I. Batal,² E. Campenot,² S. Mohan.¹

5:30pm-7:30pm: The Urine Common Rejection Module (uCRM) Is a Sentinal Assay for Graft Rejection.

T. Sigdel,¹ T. Tran,¹ O. Bestard,² F. Vincenti,¹ M. Sarwal.¹

5:30pm-7:30pm: Transcriptome Profiles in Peripheral Blood of Kidney Graft Recipients.

J.-W. Seo,¹ H. Moon,¹ Y.-G. Kim,¹ K.-H. Jeong,¹ S.-J. Ihm,² J.-Y. Moon,¹ S.-H. Lee.¹

5:30pm-7:30pm: Transitional B Cell T1/T2 Ratio Is a Prognostic Marker for Human Renal Allograft Deterioration.

A. Cherukuri,¹ D. Rothstein,¹ R. Baker.²

5:30pm-7:30pm: Urinary Exosomal Annexin A1 Is a Predictive Biomarker of Post Kidney Transplant Complications.

H. Harada,¹ T. Murakami,² C. Yamamoto,² K. Hotta,¹ N. Fukuzawa,¹ M. Mitsuhashi.²

5:30pm-7:30pm: Urinary Expression of miRNA-155, miRNA-210, miRNA-142 and CXCL-10 Production Predicts the Risk of Acute Rejection and Graft Outcome in Renal Transplant Recipients.

O. Millan,¹ K. Budde,² C. Sommerer,³ I. Aliart,¹ O. Rissling,² B. Bardaji,⁴ M. Matz,² M. Zeier,³ I. Silva,⁴ L. Guirado,⁴ M. Brunet.¹

5:30pm-7:30pm: Urine-Derived Cell Lines as a Novel Tool for Monitoring Allo-Reactivity in Kidney Transplant Patients.

C. Thieme,¹ B. Weist,¹ M. Schmück,¹ P. Reinke,¹ N. Babel.^1,2

« View all sessions from the 2016 American Transplant Congress